| First Author | Cianfarani F | Year | 2011 |
| Journal | J Invest Dermatol | Volume | 131 |
| Issue | 9 | Pages | 1821-9 |
| PubMed ID | 21654836 | Mgi Jnum | J:180910 |
| Mgi Id | MGI:5308158 | Doi | 10.1038/jid.2011.137 |
| Citation | Cianfarani F, et al. (2011) Impaired keratinocyte proliferative and clonogenic potential in transgenic mice overexpressing 14-3-3sigma in the epidermis. J Invest Dermatol 131(9):1821-9 |
| abstractText | The 14-3-3 protein family controls diverse biochemical processes through interaction with phosphorylated consensus sequences in protein targets. Its epithelial specific member, 14-3-3sigma, also known as stratifin, is highly expressed in differentiated keratinocytes, and in vitro evidence indicates that 14-3-3sigma downregulation leads to keratinocyte immortalization. To define the role of 14-3-3sigma in skin homeostasis in vivo, we generated transgenic mice overexpressing 14-3-3sigma in proliferating keratinocytes of the epidermis and hair follicle. Transgenic animals show decreased epidermal thickness and hair follicle density associated with reduced number of proliferating keratinocytes and decreased levels of keratins 14, 5, and 15. Primary keratinocytes isolated from transgenic mice manifest reduced proliferation and migration. Moreover, clonogenicity assessment and label-retaining analysis reveal a reduction in keratinocyte progenitor cell number in transgenic mice. Response to IGF-1 is strongly impaired in cultured transgenic keratinocytes compared with wild-type cells. Consistently, activation of phosphoinositol 3-kinase (PI3K), AKT, and Rac1, all IGF-1 downstream mediators, is reduced. Our results demonstrate that 14-3-3sigma controls the in vivo epidermal proliferation-differentiation switch by reducing proliferative potential and forcing keratinocytes to exit the cell cycle, and that this effect associates with inhibition of the IGF-1 pathway. |
